All Priority One drivers from Toyota, Ford and Hyundai start arriving in Nairobi on Friday for the 2025 WRC Safari Rally.The iconic Safari Rally starts on Monday with the recce followed by the ...
SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it ...
A Phase II trial of Recce Pharmaceutical’s topical skin infection gel has ‘exceeded expectations’, with 93% of patients achieving the primary efficacy endpoint. The Australian company’s ...
A successful phase II clinical trial has taken place, assessing efficacy and safety of R327G in patients with acute bacterial skin and skin structure infections Recce said objectives exceeded with ...
Recce Pharmaceuticals has shared positive data from a mid-stage study of its RECCE 327 topical gel (R327G) in acute bacterial skin and skin structure infections (ABSSSIs). The open-label phase 2 trial ...
Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the Australian biotech to point to the anti-infective's potential to counter ...
Recce Pharmaceuticals Ltd, a global company developing a new class of synthetic anti-infectives, has announced positive data from a phase II clinical trial evaluating RECCE 327 topical gel (R327G) for ...
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. A successful phase II clinical trial has taken place, assessing efficacy and safety of R327G in ...
SYDNEY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic anti-infectives, today announced it was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback